Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
South Florida Research Institute (SFRI) is a clinical research organization and trial site based in Lauderdale Lakes, Florida, specializing in Phase II through Phase IV clinical studies. Operating as the research arm of South Florida Nephrology Associates (SFNA), the institute focuses on therapeutic areas such as nephrology, endocrinology, and cardiovascular health. SFRI has established partnerships with major pharmaceutical companies, including Gilead, Vertex, and Takeda, to conduct trials for conditions like diabetic kidney disease, IgA nephropathy, and anemia. The facility is led by experienced, board-certified nephrologists who serve as principal investigators, ensuring high standards of patient care and data integrity. SFRI provides the local community with access to innovative medical treatments while supporting the global development of new therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on South Florida Research Institute.